Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids & Tox Screening Europe 2019

Grégory Maubon's Biography

Grégory Maubon, Digital Coordinator, HCS Pharma

Grégory Maubon is CDO and digital coordinator at HCS Pharma. He manages IT projects and leads digital campaigns linked to company needs. Grégory is also an Augmented Reality specialist and evangelist. In 2008 he created and later in 2010 founded RA'pro - the augmented reality promotion association. He has helped many companies, in several domains, to define and implement their augmented reality programs. Grégory is also a presenter and lecturer and is involved with the organization of events such as Laval Virtual. He has a PhD in the field of physics and astrophysics.

Grégory Maubon Image

Phenotypic Screening in 3D Culture Including ECM: Advantages and Challenges

Thursday, 13 June 2019 at 13:30

Add to Calendar ▼2019-06-13 13:30:002019-06-13 14:30:00Europe/LondonPhenotypic Screening in 3D Culture Including ECM: Advantages and Challenges3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The

Cellular assays in 3D culture have shown many advantages to better mimic the in vivo situation. 3D technologies for phenotypic screening have become simpler and more accessible, such as the use of Ultra Low Attachment (ULA) plates. However, we can now go even further using 3D technologies which allow us to reproduce the micro-environment of healthy or pathological organs of interest. During this talk, we will show how the cellular microenvironment impacts the proliferation and/or differentiation of cells. A few examples from the fields of oncology, CNS and metabolic disease will be presented. High-Content Screening (HCS) devices, such as our ImageXpress® Micro Confocal system, are now fast enough and sensitive enough to allow image acquisition in 3D cellular models. Nevertheless, to go further, perceptions and processes need to be changed. We will discuss cutting-edge new technologies, including virtual and augmented realities, deep learning and machine learning, and explain how these new technologies can be of benefit to phenotypic screening.

Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The